Lab of Biomedical Material Engineering, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China.
Biotechnol Lett. 2010 Sep;32(9):1333-7. doi: 10.1007/s10529-010-0287-8. Epub 2010 May 5.
Immunophilin ligand FK506 has been treated as adjunct therapy for nerve repair due to its potent neurotrophic and neuroprotective actions. It was hypothesized that FK506 releasing from biodegradable chitosan guide provided better nerve regenerative response than the guide with no FK506. The drug was entrapped in the semi-permeable wall of chitosan guide with the drug-loading of 647 microg/g. Rat sciatic nerve defect model treated with FK506-releasing chitosan guide showed more mature appearance of myelinated fibers 8 weeks after surgery; furthermore, the motor functional reinnervation occurred, the amplitude and velocity of compound muscle action potentials reached 60% and 73% with respect to the normal. Thus, FK506-releasing chitosan guide should be acted as a long-lasting delivery device of immunosuppressive and neuroregenerative agent for peripheral nerve repair.
免疫亲和配体 FK506 因其具有很强的神经营养和神经保护作用,被用作神经修复的辅助治疗。有人假设,从可生物降解的壳聚糖引导物中释放的 FK506 比没有 FK506 的引导物能提供更好的神经再生反应。该药物被包埋在壳聚糖引导物的半渗透壁内,载药量为 647μg/g。用 FK506 释放壳聚糖引导物治疗的大鼠坐骨神经缺损模型在手术后 8 周表现出更成熟的有髓神经纤维外观;此外,运动功能重新支配发生,复合肌肉动作电位的幅度和速度分别达到正常的 60%和 73%。因此,FK506 释放壳聚糖引导物应该作为一种用于周围神经修复的免疫抑制和神经再生剂的长效输送装置。